I think the results are key and the market facing communications are a bit more slick from ALA, but in general I agree. An each way investment is the prudent choice, particularly given the surge in M&A in the space in the US and significant growth in interest for these therapies.
I think the results are key and the market facing communications...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.3¢ |
Change
-0.001(4.17%) |
Mkt cap ! $19.69M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.3¢ | $4.671K | 199.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 406823 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 533742 | 2 |
View Market Depth
| Last trade - 13.29pm 15/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.3¢ |
Change
-0.001 ( 4.17 %) |
||||
| Open | High | Low | Volume | ||
| 2.3¢ | 2.4¢ | 2.3¢ | 1020457 | ||
| Last updated 13.29pm 15/05/2024 ? | |||||
| CHM (ASX) Chart |